Prostaglandin analogs are the most widely prescribed first-line eye drops for glaucoma, and for good reason: they lower eye pressure more effectively than any other single-drug class, require only one drop per day, and have relatively mild side effects. But “best” depends on your specific type of glaucoma, how much pressure reduction you need, other health conditions you have, and how your eyes tolerate certain ingredients. Here’s what each class of drops does and how they compare.
Prostaglandin Analogs: The First Choice
Prostaglandin analogs work by opening up a secondary drainage pathway in the eye, allowing fluid to leave more freely and lowering internal pressure. The three most common options are latanoprost, bimatoprost, and travoprost, all dosed once daily at bedtime.
In a head-to-head comparison, bimatoprost produced the largest pressure drop at 12 weeks: a 35.9% reduction from baseline, compared with 30.8% for travoprost and 29.9% for latanoprost. That translated to about 8.8 mmHg of pressure lowering with bimatoprost versus roughly 7.3 to 7.6 mmHg for the other two. However, bimatoprost also tends to cause more eye redness, so many doctors start with latanoprost for its balance of effectiveness and comfort, then switch if the response isn’t adequate.
Common side effects across this class include redness, a mild burning sensation, blurred vision right after instillation, gradual darkening of the iris color, and longer or thicker eyelash growth. These are cosmetic changes for the most part, though iris color change is permanent. Serious systemic effects are rare, which is one reason prostaglandins sit at the top of the treatment ladder.
Beta-Blockers: A Long-Standing Alternative
Beta-blocker drops, most commonly timolol, reduce eye pressure by slowing the production of fluid inside the eye rather than increasing drainage. They lower pressure by about 27% on average, making them somewhat less potent than prostaglandins. They’re usually dosed once or twice daily.
The trade-off is systemic side effects. Because some of the drug absorbs into your bloodstream through the tear ducts, beta-blocker drops can cause low blood pressure, a slower heart rate, fatigue, and shortness of breath. People with asthma, COPD, or certain heart rhythm problems generally cannot use them safely. For patients who tolerate them well, though, beta-blockers remain effective and inexpensive.
Alpha-Agonists and Carbonic Anhydrase Inhibitors
Brimonidine, the most common alpha-agonist drop, pulls double duty: it reduces fluid production and opens the secondary drainage pathway. It’s often used as an add-on when a single drop isn’t enough. Side effects tend to be mild (dry mouth, headache, fatigue), though some people develop an allergic reaction around the eyelids after weeks or months of use, which typically means switching to something else.
Carbonic anhydrase inhibitors like dorzolamide and brinzolamide also slow fluid production. They’re dosed two to three times a day when used alone, which makes adherence harder. Most patients encounter them as part of a combination bottle rather than a standalone prescription. A metallic or bitter taste after instilling the drop is common.
Rho Kinase Inhibitors: The Newest Class
Rho kinase (ROCK) inhibitors are the first new class of glaucoma drops in decades. They work differently from everything above: instead of reducing fluid production or rerouting drainage, they relax the tissue in the eye’s primary drain (the trabecular meshwork), letting fluid flow out more efficiently. Netarsudil, approved in the U.S. under the brand name Rhopressa, adds a second mechanism by lowering the pressure in the small veins that receive fluid as it exits the eye.
Clinical studies show ROCK inhibitors perform comparably to beta-blockers and prostaglandins in lowering pressure. The most noticeable side effect is eye redness, which occurs frequently but is usually mild. Some patients develop tiny, harmless swirl-shaped deposits on the cornea that disappear after stopping the medication.
Combination Drops That Simplify Your Routine
When one drop isn’t enough, your doctor may add a second medication. Using two separate bottles means twice the preservative exposure and twice the hassle, so fixed-combination drops exist to merge two drugs into a single bottle.
- Brimonidine plus timolol (Combigan): pairs an alpha-agonist with a beta-blocker.
- Dorzolamide plus timolol (Cosopt): pairs a carbonic anhydrase inhibitor with a beta-blocker.
- Brinzolamide plus brimonidine (Simbrinza): combines a carbonic anhydrase inhibitor and an alpha-agonist, avoiding beta-blockers entirely for patients who can’t use them.
- Netarsudil plus latanoprost (Rocklatan): combines the newest ROCK inhibitor class with a prostaglandin, attacking pressure from two completely different directions.
Rocklatan is notable because it pairs the two most effective pressure-lowering mechanisms in one drop, making it a strong option for people who need aggressive treatment but want to keep their regimen simple.
Preservative-Free Options
Most glaucoma drops contain a preservative called benzalkonium chloride (BAK) to prevent bacterial contamination. BAK is hard on the eye surface, and because glaucoma treatment is lifelong, years of exposure can cause chronic dryness, redness, stinging, and inflammation of the cornea. These symptoms sometimes get bad enough that patients stop using their drops altogether, which is obviously worse for the glaucoma.
Preservative-free versions now exist for several major medications. Latanoprost, bimatoprost, and tafluprost all come in single-use preservative-free vials. Timolol and dorzolamide have preservative-free versions as well, along with some combination products like dorzolamide/timolol and tafluprost/timolol. If your eyes feel chronically irritated or you already have dry eye disease, asking about a preservative-free formulation is worth the conversation. They cost more and come in individual-use packaging, but they can dramatically improve comfort and long-term adherence.
Getting the Most From Every Drop
Proper technique matters more than most people realize. A significant portion of each drop can drain through your tear ducts into your nose and throat within seconds, reducing how much medicine actually reaches the eye and increasing systemic side effects.
After instilling a drop, close your eyes and press a fingertip gently against the inner corner of your eye, right where the nose meets the lower eyelid. Hold that pressure for one to two minutes. This simple step, called punctal occlusion, blocks the tear duct and keeps the medication on the eye surface where it belongs. It’s particularly helpful with beta-blockers, where minimizing the amount reaching your bloodstream reduces the risk of heart rate and breathing changes.
If you use more than one type of drop, wait at least five minutes between them. The first drop needs time to absorb; adding a second one immediately just washes the first away. And if one of your drops is a thicker gel formulation (like some timolol products), use it last so it doesn’t block the thinner drops from absorbing.